文献速递复苏、休克与脓毒症心脑血管急症

肺栓塞致院外心脏骤停复苏期间溶栓可提高30天生存率:法国国家心脏骤停登记研究结果

Thrombolysis During Resuscitation for Out-of-Hospital Cardiac Arrest Caused by Pulmonary Embolism Increases 30-Day Survival: Findings From the French National Cardiac Arrest Registry.
PubMed 文献 · Chest · 2019-08-02
一句话结论对肺栓塞导致院外心脏骤停且复苏后恢复自主循环入院的患者,复苏期间溶栓与30天生存率更高相关(16% vs 6%)。

该回顾性、观察性、多中心研究纳入2011年7月至2018年3月法国国家心脏骤停登记中所有成人院外心脏骤停、经移动ICU处置且入院时确诊肺栓塞的患者。共14253例入院患者中328例最终诊断为肺栓塞,246例纳入分析。复苏期间溶栓组58例(阿替普酶14例24%、替奈普酶43例74%、链激酶1例2%),30天生存率溶栓组高于对照组(16% vs 6%,P=.005,校正时序检验),但良好神经功能结局无显著差异(10% vs 5%,校正相对危险度1.97,95%CI 0.70-5.56)。ICU中位停留时间溶栓组1(0-5)天 vs 对照组1(0-3)天(P=.23)。

要点

  • 肺栓塞致院外心脏骤停且复苏后恢复自主循环入院的患者,复苏期间溶栓组30天生存率16% vs 对照组6%(P=.005,校正时序检验)。
  • 良好神经功能结局溶栓组10% vs 对照组5%,校正相对危险度1.97(95%CI 0.70-5.56),未达统计学显著。
  • 溶栓组58例中阿替普酶14例(24%)、替奈普酶43例(74%)、链激酶1例(2%)。
  • ICU中位停留时间溶栓组1(0-5)天 vs 对照组1(0-3)天(P=.23)。
  • 该研究为回顾性、观察性、多中心研究,2011年7月至2018年3月法国国家心脏骤停登记数据。

适用人群与场景

  • 成人院外心脏骤停患者,经移动ICU处置,入院时确诊肺栓塞,且入院时恢复自主循环。

处置流程与药物剂量

  • 复苏期间溶栓组58例中,阿替普酶14例(24%)、替奈普酶43例(74%)、链激酶1例(2%);原文未写明各药剂量、给药途径、频次或疗程。

研究设计与关键结果

  • 回顾性、观察性、多中心研究,2011年7月至2018年3月,共14253例入院患者中328例最终诊断肺栓塞,246例纳入分析。
  • 复苏期间溶栓组58例,对照组为未溶栓患者;30天生存率溶栓组16% vs 对照组6%(P=.005,校正时序检验)。
  • 良好神经功能结局溶栓组10% vs 对照组5%,校正相对危险度1.97(95%CI 0.70-5.56),未达统计学显著。
  • ICU中位停留时间溶栓组1(0-5)天 vs 对照组1(0-3)天(P=.23)。

证据类型、等级与局限

  • 证据类型:回顾性、观察性、多中心研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于肺栓塞导致院外心脏骤停、经移动ICU处置且入院时恢复自主循环的成人患者,复苏期间溶栓与更高的30天生存率相关(16% vs 6%),但良好神经功能结局无显著差异(10% vs 5%,校正相对危险度1.97,95%CI 0.70-5.56)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Pulmonary embolism (PE) represents 2% to 5% of all causes of out-of-hospital cardiac arrest (OHCA) and is associated with extremely unfavorable prognosis. In PE-related OHCA, inconsistent data showed that thrombolysis during cardiopulmonary resuscitation may favor survival.

METHODS: This was a retrospective, observational, multicenter study from July 2011 to March 2018. All adults with OHCA, treated by a mobile ICU and with a diagnosis of PE confirmed on hospital admission, were included. The primary end point was 30-day survival in a weighted population.

RESULTS: Of the 14,253 patients admitted to hospitals, 328 had a final diagnosis of PE and 246 were included in the analysis. In the group that received thrombolysis during resuscitation (n = 58), 14 (24%) received alteplase, 43 (74%) received tenecteplase, and one (2%) received streptokinase. Thirty-day survival was higher in the thrombolysis group than in the control group (16% vs 6%; P = .005; adjusted log-rank test) but the good neurologic outcome was not significantly different (10% vs 5%; adjusted relative risk, 1.97; 95% CI, 0.70-5.56). Median duration of stay in the ICU was 1 (0-5) day for the thrombolysis group and 1 (0-3) day for the control group (P = .23).

CONCLUSIONS: In patients with OHCA with confirmed PE and admitted with recuperation of spontaneous circulation in the hospital, there was significantly higher 30-day survival in those who received thrombolysis during cardiopulmonary resuscitation compared with patients who did not receive thrombolysis.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Javaudin F, Lascarrou JB, Le Bastard Q, et al. Thrombolysis During Resuscitation for Out-of-Hospital Cardiac Arrest Caused by Pulmonary Embolism Increases 30-Day Survival: Findings From the French National Cardiac Arrest Registry. Chest. 2019. PMID: 31381884. doi:10.1016/j.chest.2019.07.015

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。